Valneva Announces Successful Outcome of its Annual General Meeting - Valneva

Skip to content

Lyon (France), June 25, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company (“the Company”), today announced that shareholders approved all resolutions recommended by the Board of Directors at the Company’s Annual General Meeting (AGM), held earlier today in Lyon, France.

To access the full release, please click on the PDF below.

Press release

We use cookies to improve the functionality and user experience of the website and to analyse the traffic. You can find detailed information in our Privacy Policy . ACCEPT REJECT CHANGE MY PREFERENCES